The global market for Biologic Therapeutics Drugs was valued at US$ 361940 million in the year 2024 and is projected to reach a revised size of US$ 541510 million by 2031, growing at a CAGR of 6.0% during the forecast period.

Biologic Therapeutics Drugs Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Biologic Therapeutics Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Biologic Therapeutics Drugs.

The Biologic Therapeutics Drugs market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Biologic Therapeutics Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Biologic Therapeutics Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Biologic Therapeutics Drugs Market Report

Report Metric	Details
Report Name	Biologic Therapeutics Drugs Market
Accounted market size in year	US$ 361940 million
Forecasted market size in 2031	US$ 541510 million
CAGR	6.0%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Avian Cell Culture Yeast Bacteria Insects Cell Culture Transgenics
Segment by Application	Rheumatoid Arthritis Anemia Cancer Diabetes Others
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Pfizer, AstraZeneca, Novartis, Merck, Smith Medical, GlaxoSmithKline, Concord Biotech, Aurobindo Pharma, H. Lundbeck, Retractable Technologies
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Biologic Therapeutics Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Biologic Therapeutics Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Biologic Therapeutics Drugs Market growing?

Ans: The Biologic Therapeutics Drugs Market witnessing a CAGR of 6.0% during the forecast period 2025-2031.

What is the Biologic Therapeutics Drugs Market size in 2031?

Ans: The Biologic Therapeutics Drugs Market size in 2031 will be US$ 541510 million.

Who are the main players in the Biologic Therapeutics Drugs Market report?

Ans: The main players in the Biologic Therapeutics Drugs Market are Pfizer, AstraZeneca, Novartis, Merck, Smith Medical, GlaxoSmithKline, Concord Biotech, Aurobindo Pharma, H. Lundbeck, Retractable Technologies

What are the Application segmentation covered in the Biologic Therapeutics Drugs Market report?

Ans: The Applications covered in the Biologic Therapeutics Drugs Market report are Rheumatoid Arthritis, Anemia, Cancer, Diabetes, Others

What are the Type segmentation covered in the Biologic Therapeutics Drugs Market report?

Ans: The Types covered in the Biologic Therapeutics Drugs Market report are Avian Cell Culture, Yeast, Bacteria, Insects Cell Culture, Transgenics

1 Biologic Therapeutics Drugs Market Overview

1.1 Product Definition

1.2 Biologic Therapeutics Drugs by Type

1.2.1 Global Biologic Therapeutics Drugs Market Value Comparison by Type (2024 VS 2031)

1.2.2 Avian Cell Culture

1.2.3 Yeast

1.2.4 Bacteria

1.2.5 Insects Cell Culture

1.2.6 Transgenics

1.3 Biologic Therapeutics Drugs by Application

1.3.1 Global Biologic Therapeutics Drugs Market Value by Application (2024 VS 2031)

1.3.2 Rheumatoid Arthritis

1.3.3 Anemia

1.3.4 Cancer

1.3.5 Diabetes

1.3.6 Others

1.4 Global Biologic Therapeutics Drugs Market Size Estimates and Forecasts

1.4.1 Global Biologic Therapeutics Drugs Revenue 2020-2031

1.4.2 Global Biologic Therapeutics Drugs Sales 2020-2031

1.4.3 Global Biologic Therapeutics Drugs Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Biologic Therapeutics Drugs Market Competition by Manufacturers

2.1 Global Biologic Therapeutics Drugs Sales Market Share by Manufacturers (2020-2025)

2.2 Global Biologic Therapeutics Drugs Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Biologic Therapeutics Drugs Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Biologic Therapeutics Drugs, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Biologic Therapeutics Drugs, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Biologic Therapeutics Drugs, Product Type & Application

2.7 Global Key Manufacturers of Biologic Therapeutics Drugs, Date of Enter into This Industry

2.8 Global Biologic Therapeutics Drugs Market Competitive Situation and Trends

2.8.1 Global Biologic Therapeutics Drugs Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Biologic Therapeutics Drugs Players Market Share by Revenue

2.8.3 Global Biologic Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Biologic Therapeutics Drugs Market Scenario by Region

3.1 Global Biologic Therapeutics Drugs Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Biologic Therapeutics Drugs Sales by Region: 2020-2031

3.2.1 Global Biologic Therapeutics Drugs Sales by Region: 2020-2025

3.2.2 Global Biologic Therapeutics Drugs Sales by Region: 2026-2031

3.3 Global Biologic Therapeutics Drugs Revenue by Region: 2020-2031

3.3.1 Global Biologic Therapeutics Drugs Revenue by Region: 2020-2025

3.3.2 Global Biologic Therapeutics Drugs Revenue by Region: 2026-2031

3.4 North America Biologic Therapeutics Drugs Market Facts & Figures by Country

3.4.1 North America Biologic Therapeutics Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Biologic Therapeutics Drugs Sales by Country (2020-2031)

3.4.3 North America Biologic Therapeutics Drugs Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Biologic Therapeutics Drugs Market Facts & Figures by Country

3.5.1 Europe Biologic Therapeutics Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Biologic Therapeutics Drugs Sales by Country (2020-2031)

3.5.3 Europe Biologic Therapeutics Drugs Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Biologic Therapeutics Drugs Market Facts & Figures by Region

3.6.1 Asia Pacific Biologic Therapeutics Drugs Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Biologic Therapeutics Drugs Sales by Region (2020-2031)

3.6.3 Asia Pacific Biologic Therapeutics Drugs Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Biologic Therapeutics Drugs Market Facts & Figures by Country

3.7.1 Latin America Biologic Therapeutics Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Biologic Therapeutics Drugs Sales by Country (2020-2031)

3.7.3 Latin America Biologic Therapeutics Drugs Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Biologic Therapeutics Drugs Market Facts & Figures by Country

3.8.1 Middle East and Africa Biologic Therapeutics Drugs Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Biologic Therapeutics Drugs Sales by Country (2020-2031)

3.8.3 Middle East and Africa Biologic Therapeutics Drugs Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Biologic Therapeutics Drugs Sales by Type (2020-2031)

4.1.1 Global Biologic Therapeutics Drugs Sales by Type (2020-2025)

4.1.2 Global Biologic Therapeutics Drugs Sales by Type (2026-2031)

4.1.3 Global Biologic Therapeutics Drugs Sales Market Share by Type (2020-2031)

4.2 Global Biologic Therapeutics Drugs Revenue by Type (2020-2031)

4.2.1 Global Biologic Therapeutics Drugs Revenue by Type (2020-2025)

4.2.2 Global Biologic Therapeutics Drugs Revenue by Type (2026-2031)

4.2.3 Global Biologic Therapeutics Drugs Revenue Market Share by Type (2020-2031)

4.3 Global Biologic Therapeutics Drugs Price by Type (2020-2031)

5 Segment by Application

5.1 Global Biologic Therapeutics Drugs Sales by Application (2020-2031)

5.1.1 Global Biologic Therapeutics Drugs Sales by Application (2020-2025)

5.1.2 Global Biologic Therapeutics Drugs Sales by Application (2026-2031)

5.1.3 Global Biologic Therapeutics Drugs Sales Market Share by Application (2020-2031)

5.2 Global Biologic Therapeutics Drugs Revenue by Application (2020-2031)

5.2.1 Global Biologic Therapeutics Drugs Revenue by Application (2020-2025)

5.2.2 Global Biologic Therapeutics Drugs Revenue by Application (2026-2031)

5.2.3 Global Biologic Therapeutics Drugs Revenue Market Share by Application (2020-2031)

5.3 Global Biologic Therapeutics Drugs Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Pfizer

6.1.1 Pfizer Company Information

6.1.2 Pfizer Description and Business Overview

6.1.3 Pfizer Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Pfizer Biologic Therapeutics Drugs Product Portfolio

6.1.5 Pfizer Recent Developments/Updates

6.2 AstraZeneca

6.2.1 AstraZeneca Company Information

6.2.2 AstraZeneca Description and Business Overview

6.2.3 AstraZeneca Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2020-2025)

6.2.4 AstraZeneca Biologic Therapeutics Drugs Product Portfolio

6.2.5 AstraZeneca Recent Developments/Updates

6.3 Novartis

6.3.1 Novartis Company Information

6.3.2 Novartis Description and Business Overview

6.3.3 Novartis Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Novartis Biologic Therapeutics Drugs Product Portfolio

6.3.5 Novartis Recent Developments/Updates

6.4 Merck

6.4.1 Merck Company Information

6.4.2 Merck Description and Business Overview

6.4.3 Merck Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Merck Biologic Therapeutics Drugs Product Portfolio

6.4.5 Merck Recent Developments/Updates

6.5 Smith Medical

6.5.1 Smith Medical Company Information

6.5.2 Smith Medical Description and Business Overview

6.5.3 Smith Medical Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Smith Medical Biologic Therapeutics Drugs Product Portfolio

6.5.5 Smith Medical Recent Developments/Updates

6.6 GlaxoSmithKline

6.6.1 GlaxoSmithKline Company Information

6.6.2 GlaxoSmithKline Description and Business Overview

6.6.3 GlaxoSmithKline Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2020-2025)

6.6.4 GlaxoSmithKline Biologic Therapeutics Drugs Product Portfolio

6.6.5 GlaxoSmithKline Recent Developments/Updates

6.7 Concord Biotech

6.7.1 Concord Biotech Company Information

6.7.2 Concord Biotech Description and Business Overview

6.7.3 Concord Biotech Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Concord Biotech Biologic Therapeutics Drugs Product Portfolio

6.7.5 Concord Biotech Recent Developments/Updates

6.8 Aurobindo Pharma

6.8.1 Aurobindo Pharma Company Information

6.8.2 Aurobindo Pharma Description and Business Overview

6.8.3 Aurobindo Pharma Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Aurobindo Pharma Biologic Therapeutics Drugs Product Portfolio

6.8.5 Aurobindo Pharma Recent Developments/Updates

6.9 H. Lundbeck

6.9.1 H. Lundbeck Company Information

6.9.2 H. Lundbeck Description and Business Overview

6.9.3 H. Lundbeck Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2020-2025)

6.9.4 H. Lundbeck Biologic Therapeutics Drugs Product Portfolio

6.9.5 H. Lundbeck Recent Developments/Updates

6.10 Retractable Technologies

6.10.1 Retractable Technologies Company Information

6.10.2 Retractable Technologies Description and Business Overview

6.10.3 Retractable Technologies Biologic Therapeutics Drugs Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Retractable Technologies Biologic Therapeutics Drugs Product Portfolio

6.10.5 Retractable Technologies Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Biologic Therapeutics Drugs Industry Chain Analysis

7.2 Biologic Therapeutics Drugs Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Biologic Therapeutics Drugs Production Mode & Process Analysis

7.4 Biologic Therapeutics Drugs Sales and Marketing

7.4.1 Biologic Therapeutics Drugs Sales Channels

7.4.2 Biologic Therapeutics Drugs Distributors

7.5 Biologic Therapeutics Drugs Customer Analysis

8 Biologic Therapeutics Drugs Market Dynamics

8.1 Biologic Therapeutics Drugs Industry Trends

8.2 Biologic Therapeutics Drugs Market Drivers

8.3 Biologic Therapeutics Drugs Market Challenges

8.4 Biologic Therapeutics Drugs Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Retractable Technologies

List of Tables

Table 1. Global Biologic Therapeutics Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Biologic Therapeutics Drugs Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Biologic Therapeutics Drugs Market Competitive Situation by Manufacturers in 2024

Table 4. Global Biologic Therapeutics Drugs Sales (Units) of Key Manufacturers (2020-2025)

Table 5. Global Biologic Therapeutics Drugs Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Biologic Therapeutics Drugs Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Biologic Therapeutics Drugs Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Biologic Therapeutics Drugs Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Biologic Therapeutics Drugs, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Biologic Therapeutics Drugs, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Biologic Therapeutics Drugs, Product Type & Application

Table 12. Global Key Manufacturers of Biologic Therapeutics Drugs, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Biologic Therapeutics Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologic Therapeutics Drugs as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Biologic Therapeutics Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Biologic Therapeutics Drugs Sales by Region (2020-2025) & (Units)

Table 18. Global Biologic Therapeutics Drugs Sales Market Share by Region (2020-2025)

Table 19. Global Biologic Therapeutics Drugs Sales by Region (2026-2031) & (Units)

Table 20. Global Biologic Therapeutics Drugs Sales Market Share by Region (2026-2031)

Table 21. Global Biologic Therapeutics Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Biologic Therapeutics Drugs Revenue Market Share by Region (2020-2025)

Table 23. Global Biologic Therapeutics Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Biologic Therapeutics Drugs Revenue Market Share by Region (2026-2031)

Table 25. North America Biologic Therapeutics Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Biologic Therapeutics Drugs Sales by Country (2020-2025) & (Units)

Table 27. North America Biologic Therapeutics Drugs Sales by Country (2026-2031) & (Units)

Table 28. North America Biologic Therapeutics Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Biologic Therapeutics Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Biologic Therapeutics Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Biologic Therapeutics Drugs Sales by Country (2020-2025) & (Units)

Table 32. Europe Biologic Therapeutics Drugs Sales by Country (2026-2031) & (Units)

Table 33. Europe Biologic Therapeutics Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Biologic Therapeutics Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Biologic Therapeutics Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Biologic Therapeutics Drugs Sales by Region (2020-2025) & (Units)

Table 37. Asia Pacific Biologic Therapeutics Drugs Sales by Region (2026-2031) & (Units)

Table 38. Asia Pacific Biologic Therapeutics Drugs Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Biologic Therapeutics Drugs Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Biologic Therapeutics Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Biologic Therapeutics Drugs Sales by Country (2020-2025) & (Units)

Table 42. Latin America Biologic Therapeutics Drugs Sales by Country (2026-2031) & (Units)

Table 43. Latin America Biologic Therapeutics Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Biologic Therapeutics Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Biologic Therapeutics Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Biologic Therapeutics Drugs Sales by Country (2020-2025) & (Units)

Table 47. Middle East and Africa Biologic Therapeutics Drugs Sales by Country (2026-2031) & (Units)

Table 48. Middle East and Africa Biologic Therapeutics Drugs Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Biologic Therapeutics Drugs Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Biologic Therapeutics Drugs Sales (Units) by Type (2020-2025)

Table 51. Global Biologic Therapeutics Drugs Sales (Units) by Type (2026-2031)

Table 52. Global Biologic Therapeutics Drugs Sales Market Share by Type (2020-2025)

Table 53. Global Biologic Therapeutics Drugs Sales Market Share by Type (2026-2031)

Table 54. Global Biologic Therapeutics Drugs Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Biologic Therapeutics Drugs Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Biologic Therapeutics Drugs Revenue Market Share by Type (2020-2025)

Table 57. Global Biologic Therapeutics Drugs Revenue Market Share by Type (2026-2031)

Table 58. Global Biologic Therapeutics Drugs Price (USD/Unit) by Type (2020-2025)

Table 59. Global Biologic Therapeutics Drugs Price (USD/Unit) by Type (2026-2031)

Table 60. Global Biologic Therapeutics Drugs Sales (Units) by Application (2020-2025)

Table 61. Global Biologic Therapeutics Drugs Sales (Units) by Application (2026-2031)

Table 62. Global Biologic Therapeutics Drugs Sales Market Share by Application (2020-2025)

Table 63. Global Biologic Therapeutics Drugs Sales Market Share by Application (2026-2031)

Table 64. Global Biologic Therapeutics Drugs Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Biologic Therapeutics Drugs Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Biologic Therapeutics Drugs Revenue Market Share by Application (2020-2025)

Table 67. Global Biologic Therapeutics Drugs Revenue Market Share by Application (2026-2031)

Table 68. Global Biologic Therapeutics Drugs Price (USD/Unit) by Application (2020-2025)

Table 69. Global Biologic Therapeutics Drugs Price (USD/Unit) by Application (2026-2031)

Table 70. Pfizer Company Information

Table 71. Pfizer Description and Business Overview

Table 72. Pfizer Biologic Therapeutics Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Pfizer Biologic Therapeutics Drugs Product

Table 74. Pfizer Recent Developments/Updates

Table 75. AstraZeneca Company Information

Table 76. AstraZeneca Description and Business Overview

Table 77. AstraZeneca Biologic Therapeutics Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. AstraZeneca Biologic Therapeutics Drugs Product

Table 79. AstraZeneca Recent Developments/Updates

Table 80. Novartis Company Information

Table 81. Novartis Description and Business Overview

Table 82. Novartis Biologic Therapeutics Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Novartis Biologic Therapeutics Drugs Product

Table 84. Novartis Recent Developments/Updates

Table 85. Merck Company Information

Table 86. Merck Description and Business Overview

Table 87. Merck Biologic Therapeutics Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Merck Biologic Therapeutics Drugs Product

Table 89. Merck Recent Developments/Updates

Table 90. Smith Medical Company Information

Table 91. Smith Medical Description and Business Overview

Table 92. Smith Medical Biologic Therapeutics Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. Smith Medical Biologic Therapeutics Drugs Product

Table 94. Smith Medical Recent Developments/Updates

Table 95. GlaxoSmithKline Company Information

Table 96. GlaxoSmithKline Description and Business Overview

Table 97. GlaxoSmithKline Biologic Therapeutics Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. GlaxoSmithKline Biologic Therapeutics Drugs Product

Table 99. GlaxoSmithKline Recent Developments/Updates

Table 100. Concord Biotech Company Information

Table 101. Concord Biotech Description and Business Overview

Table 102. Concord Biotech Biologic Therapeutics Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. Concord Biotech Biologic Therapeutics Drugs Product

Table 104. Concord Biotech Recent Developments/Updates

Table 105. Aurobindo Pharma Company Information

Table 106. Aurobindo Pharma Description and Business Overview

Table 107. Aurobindo Pharma Biologic Therapeutics Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. Aurobindo Pharma Biologic Therapeutics Drugs Product

Table 109. Aurobindo Pharma Recent Developments/Updates

Table 110. H. Lundbeck Company Information

Table 111. H. Lundbeck Description and Business Overview

Table 112. H. Lundbeck Biologic Therapeutics Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 113. H. Lundbeck Biologic Therapeutics Drugs Product

Table 114. H. Lundbeck Recent Developments/Updates

Table 115. Retractable Technologies Company Information

Table 116. Retractable Technologies Description and Business Overview

Table 117. Retractable Technologies Biologic Therapeutics Drugs Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 118. Retractable Technologies Biologic Therapeutics Drugs Product

Table 119. Retractable Technologies Recent Developments/Updates

Table 120. Key Raw Materials Lists

Table 121. Raw Materials Key Suppliers Lists

Table 122. Biologic Therapeutics Drugs Distributors List

Table 123. Biologic Therapeutics Drugs Customers List

Table 124. Biologic Therapeutics Drugs Market Trends

Table 125. Biologic Therapeutics Drugs Market Drivers

Table 126. Biologic Therapeutics Drugs Market Challenges

Table 127. Biologic Therapeutics Drugs Market Restraints

Table 128. Research Programs/Design for This Report

Table 129. Key Data Information from Secondary Sources

Table 130. Key Data Information from Primary Sources

Table 131. Authors List of This Report

List of Figures

Figure 1. Product Picture of Biologic Therapeutics Drugs

Figure 2. Global Biologic Therapeutics Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Biologic Therapeutics Drugs Market Share by Type: 2024 & 2031

Figure 4. Avian Cell Culture Product Picture

Figure 5. Yeast Product Picture

Figure 6. Bacteria Product Picture

Figure 7. Insects Cell Culture Product Picture

Figure 8. Transgenics Product Picture

Figure 9. Global Biologic Therapeutics Drugs Market Value by Application (2020-2031) & (US$ Million)

Figure 10. Global Biologic Therapeutics Drugs Market Share by Application: 2024 & 2031

Figure 11. Rheumatoid Arthritis

Figure 12. Anemia

Figure 13. Cancer

Figure 14. Diabetes

Figure 15. Others

Figure 16. Global Biologic Therapeutics Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Biologic Therapeutics Drugs Market Size (2020-2031) & (US$ Million)

Figure 18. Global Biologic Therapeutics Drugs Sales (2020-2031) & (Units)

Figure 19. Global Biologic Therapeutics Drugs Average Price (USD/Unit) & (2020-2031)

Figure 20. Biologic Therapeutics Drugs Report Years Considered

Figure 21. Biologic Therapeutics Drugs Sales Share by Manufacturers in 2024

Figure 22. Global Biologic Therapeutics Drugs Revenue Share by Manufacturers in 2024

Figure 23. Global 5 and 10 Largest Biologic Therapeutics Drugs Players: Market Share by Revenue in Biologic Therapeutics Drugs in 2024

Figure 24. Biologic Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 25. Global Biologic Therapeutics Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 26. North America Biologic Therapeutics Drugs Sales Market Share by Country (2020-2031)

Figure 27. North America Biologic Therapeutics Drugs Revenue Market Share by Country (2020-2031)

Figure 28. U.S. Biologic Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. Canada Biologic Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Europe Biologic Therapeutics Drugs Sales Market Share by Country (2020-2031)

Figure 31. Europe Biologic Therapeutics Drugs Revenue Market Share by Country (2020-2031)

Figure 32. Germany Biologic Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. France Biologic Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. U.K. Biologic Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Italy Biologic Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Russia Biologic Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Asia Pacific Biologic Therapeutics Drugs Sales Market Share by Region (2020-2031)

Figure 38. Asia Pacific Biologic Therapeutics Drugs Revenue Market Share by Region (2020-2031)

Figure 39. China Biologic Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Japan Biologic Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. South Korea Biologic Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. India Biologic Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Australia Biologic Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Taiwan Biologic Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Indonesia Biologic Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Thailand Biologic Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Malaysia Biologic Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Philippines Biologic Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Latin America Biologic Therapeutics Drugs Sales Market Share by Country (2020-2031)

Figure 50. Latin America Biologic Therapeutics Drugs Revenue Market Share by Country (2020-2031)

Figure 51. Mexico Biologic Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Brazil Biologic Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Argentina Biologic Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Middle East and Africa Biologic Therapeutics Drugs Sales Market Share by Country (2020-2031)

Figure 55. Middle East and Africa Biologic Therapeutics Drugs Revenue Market Share by Country (2020-2031)

Figure 56. Turkey Biologic Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 57. Saudi Arabia Biologic Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 58. U.A.E Biologic Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 59. Global Sales Market Share of Biologic Therapeutics Drugs by Type (2020-2031)

Figure 60. Global Revenue Market Share of Biologic Therapeutics Drugs by Type (2020-2031)

Figure 61. Global Biologic Therapeutics Drugs Price (USD/Unit) by Type (2020-2031)

Figure 62. Global Sales Market Share of Biologic Therapeutics Drugs by Application (2020-2031)

Figure 63. Global Revenue Market Share of Biologic Therapeutics Drugs by Application (2020-2031)

Figure 64. Global Biologic Therapeutics Drugs Price (USD/Unit) by Application (2020-2031)

Figure 65. Biologic Therapeutics Drugs Value Chain

Figure 66. Channels of Distribution (Direct Vs Distribution)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Pharmacy Chatbot Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10T20319

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Inline Pharmaceutical Packaging Leak Detection System Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-6Q20319

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Radiological Marker Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-35Z19949

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Pharmaceutical Biomanufacturing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-26E19785

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions